As of Oct 2, 2026 close
- Assets (AUM)
- $32.36M
- Expense ratio
- 0.44%
- Dividend yield
- 0.49%
- Holdings
- 120
- 52-week range
- $27.57$36.72
- Volume (live)
- -
- Avg. volume (3M)
- 6.89K
TMED ETF: T. Rowe Price Health Care ETF - Price, Holdings & Analysis
T. Rowe Price Health Care ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $33.20 - $33.56 |
|---|---|
| 52-Week High | $36.72 |
| 52-Week Low | $27.57 |
| Open | $33.21 |
| Volume (last close) | 4.62K |
| Average Volume (3M) | 6.89K |
| Assets (AUM) | 32.36M |
|---|---|
| Expense Ratio | 0.44% |
| Total Holdings | 120 |
| Inception Date | Jun 10, 2025 |
| 1 Day Change | −0.35% |
|---|---|
| 1 Month Change | −4.74% |
| 6 Month Change | +10.30% |
| YTD Change | +11.91% |
| 1 Year Change | +17.73% |
| 50-Day MA | $34.74 |
|---|---|
| 200-Day MA | $31.77 |
| RSI | 38.80 |
| Stochastic %K | 5.67 |
| Stochastic %D | 15.33 |
| Annual Dividend | $0.16 |
|---|---|
| Dividend Yield | 0.49% |
| Last Dividend Ex-Date | Dec 23, 2025 |
TMED at a Glance
T. Rowe Price Health Care ETF (TMED) is an equity ETF from T. Rowe Price, launched in June 2025. It manages $32.36M in assets and charges a 0.44% expense ratio, about $44 a year per $10,000 invested.
It holds 120 positions. The largest are Eli Lilly and Company (LLY, 12.08%), Alnylam Pharmaceuticals, Inc (ALNY, 5.81%) and UnitedHealth Group Incorporated (UNH, 5.53%). The top 10 holdings make up 45.8% of the fund. By sector it leans toward Healthcare (100.0%). 95.4% of assets are in the United States.
It pays distributions yielding 0.49%, $0.16 per share over the last year. The share price is up 17.7% over one year (price change, excluding distributions).
Frequently Asked Questions About T. Rowe Price Health Care ETF
What is the current price of TMED?
The latest TMED price is $33.20 (Oct 7, 2026 close). The 52-week range is $27.57–$36.72. TMED has returned 17.7% over the past year.
What is the expense ratio for TMED?
TMED's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does TMED pay dividends?
Yes, TMED pays a 0.49% dividend yield. The last ex-dividend date was 2025-12-23. View full dividend history in the Dividends section.
What are the top holdings of TMED?
TMED's largest holdings are Eli Lilly and Company (12.1%), Alnylam Pharmaceuticals, Inc (5.8%), UnitedHealth Group Incorporated (5.5%) (combined weight: 23.4%). The fund holds 120 total positions. View the complete portfolio breakdown in the Holdings section.
How does TMED compare to similar ETFs?
Compare TMED (0.44% expense ratio, $32M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.